SOURCE: Xtalks

Xtalks Webinars

April 20, 2016 07:00 ET

Mastering Oncology Immunotherapy Clinical Trials: The Smaller Biopharmaceutical Perspective, New Webinar Hosted by Xtalks

TORONTO, ON --(Marketwired - April 20, 2016) - This complimentary webinar explores challenges smaller companies should consider when embarking on immunotherapy studies. The live broadcast on Thursday, May 5, 2016 at 11am EDT (4pm BST/UK), will feature industry experts from Novella Clinical, including Andrew Zupnick, Ph.D., vice president of oncology strategy, and Julia Lawrence, D.O., senior medical director, as the keynote speakers.

The reality of leveraging a patient's immune system to disrupt cancer through immunotherapy is compelling. Standards of care are shifting and drug developers are eager to leverage new technologies. Small to mid-sized biopharma companies play significant roles in innovating and adapting drug designs to create new immunotherapies, and often require outsourcing support to manage clinical investigations.

In this webinar, the speakers will explore five areas of focus for smaller companies to understand in order to fully leverage the potential of immunotherapy candidates -- and get it right the first time.

  • Protocol design and endpoint selection
  • Retaining the right patients
  • Dose-escalation strategies and measuring response
  • Reaction
  • Patient education

Learning Objectives

  • Learn what to include in a well-written protocol to ensure successful recruitment and data collection, as well as guidance for investigators and site staff new to immunotherapy trials
  • Understand how to select measurable endpoints and when to consider pharmacodynamic (PD) endpoints for bioequivalence studies
  • Gain an understanding of dosing and patient response challenges unique to immunotherapy trials, including dose-escalation, irRC versus RECIST, and pseudo disease progression
  • Recognize the distinct challenges smaller companies face when embarking on immunotherapy studies

To register or learn more about this one-hour complimentary webinar visit: Mastering Oncology Immunotherapy Clinical Trials: The Smaller Biopharmaceutical Perspective

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2016/4/19/11G094125/Images/V-Novella_Clinical-4C-831863263649.jpg

Contact Information